Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.
HRES 685 advocates for routine antiphospholipid syndrome testing in prenatal care, aiming to improve outcomes for at-risk pregnant individuals through early detection.